These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8014526)

  • 1. Complement and antibody in neutrophil-mediated killing of type V group B streptococcus.
    Hall MA; Hickman ME; Baker CJ; Edwards MS
    J Infect Dis; 1994 Jul; 170(1):88-93. PubMed ID: 8014526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement and antibody participation in opsonophagocytosis of type IV and V group B streptococci.
    Hall MA; Edwards MS; Baker CJ
    Infect Immun; 1992 Dec; 60(12):5030-5. PubMed ID: 1452334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative role for specific antibody in neutrophil bactericidal activity against highly pathogenic group B streptococci.
    Cleat PH; Coid CR
    Br J Exp Pathol; 1982 Aug; 63(4):452-7. PubMed ID: 6817779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils.
    Smith CL; Baker CJ; Anderson DC; Edwards MS
    J Infect Dis; 1990 Aug; 162(2):489-95. PubMed ID: 2197341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.
    Payne NR; Kim YK; Ferrieri P
    Infect Immun; 1987 May; 55(5):1243-51. PubMed ID: 3552996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci.
    Noya FJ; Baker CJ; Edwards MS
    Infect Immun; 1993 Apr; 61(4):1415-20. PubMed ID: 8454344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement.
    Anderson DC; Hughes BJ; Edwards MS; Buffone GJ; Baker CJ
    Pediatr Res; 1983 Jun; 17(6):496-502. PubMed ID: 6348689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus.
    Amaya RA; Baker CJ; Keitel WA; Edwards MS
    J Am Geriatr Soc; 2004 Jan; 52(1):46-50. PubMed ID: 14687314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.
    Edwards MS; Wessels MR; Baker CJ
    Infect Immun; 1993 Jul; 61(7):2866-71. PubMed ID: 8514389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.
    Albanyan EA; Edwards MS
    Infect Immun; 2000 Oct; 68(10):5794-802. PubMed ID: 10992487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis.
    Gaglani MJ; Baker CJ; Edwards MS
    J Clin Immunol; 1997 Nov; 17(6):478-84. PubMed ID: 9418188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
    Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
    Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium.
    Rakita RM; Quan VC; Jacques-Palaz K; Singh KV; Arduino RC; Mee M; Murray BE
    FEMS Immunol Med Microbiol; 2000 Aug; 28(4):291-9. PubMed ID: 10891652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
    Shigeoka AO; Jensen CL; Pincus SH; Hill HR
    J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
    Rainard P; Sarradin P; Poutrel B
    Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement and antibody in opsonophagocytosis of type II group B streptococci.
    Baker CJ; Webb BJ; Kasper DL; Edwards MS
    J Infect Dis; 1986 Jul; 154(1):47-54. PubMed ID: 3519791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci.
    Cheng Q; Carlson B; Pillai S; Eby R; Edwards L; Olmsted SB; Cleary P
    Infect Immun; 2001 Apr; 69(4):2302-8. PubMed ID: 11254587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.
    Levy NJ; Kasper DL
    Infect Immun; 1985 Jul; 49(1):19-24. PubMed ID: 3891622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of group B streptococcal opacity variants with the host defense system.
    Pincus SH; Cole RL; Kamanga-Sollo E; Fischer SH
    Infect Immun; 1993 Sep; 61(9):3761-8. PubMed ID: 8359897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.